Genzyme files suit against Transkaryotic

GENZ filed suit against TKTX in the U.S. District Court in Wilmington, Del., claiming that TKTX's Replagal agalsidase alfa replacement therapy for Fabry disease infringes GENZ's U.S. patent No. 5,356,...